PA21 Safety and Efficacy in Adult Chinese Subjects

Clinical trial NCT03644264 · COMPLETED

Trial details

NCT number: NCT03644264
Sponsor: Vifor Fresenius Medical Care Renal Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease Requiring Chronic Dialysis Hyperphosphatemia

Start date: 2018-08-31
Primary completion: 2020-08-21
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.